Related references
Note: Only part of the references are listed.Roles of microRNAs during prostatic tumorigenesis and tumor progression
Y-X Fang et al.
ONCOGENE (2014)
Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100)
Y. Loriot et al.
ANNALS OF ONCOLOGY (2013)
Androgen receptor primes prostate cancer cells to apoptosis through down-regulation of basal p21 expression
Yuting Lin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Epigenetic Repression of miR-31 Disrupts Androgen Receptor Homeostasis and Contributes to Prostate Cancer Progression
Pei-Chun Lin et al.
CANCER RESEARCH (2013)
Androgen Receptor Splice Variants Mediate Enzalutamide Resistance in Castration-Resistant Prostate Cancer Cell Lines
Yingming Li et al.
CANCER RESEARCH (2013)
The Steroid Receptor Coactivator-3 Is Required for the Development of Castration-Resistant Prostate Cancer
Jean C-Y. Tien et al.
CANCER RESEARCH (2013)
Hsp27 Regulates Epithelial Mesenchymal Transition, Metastasis, and Circulating Tumor Cells in Prostate Cancer
Masaki Shiota et al.
CANCER RESEARCH (2013)
PXD101 potentiates hormonal therapy and prevents the onset of castration-resistant phenotype modulating androgen receptor, HSP90, and CRM1 in preclinical models of prostate cancer
Giovanni Luca Gravina et al.
ENDOCRINE-RELATED CANCER (2013)
Effect of a novel 17,20-lyase inhibitor, orteronel (TAK-700), on androgen synthesis in male rats
Takahito Hara et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2013)
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
Charles J. Ryan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma
K. Boll et al.
ONCOGENE (2013)
The activity of the androgen receptor variant AR-V7 is regulated by FOXO1 in a PTEN-PI3K-AKT-dependent way
Sanjay N. Mediwala et al.
PROSTATE (2013)
Androgen receptor splice variants are resistant to inhibitors of Hsp90 and FKBP52, which alter androgen receptor activity and expression
Ayesha A. Shafi et al.
STEROIDS (2013)
PIAS1 Is Increased in Human Prostate Cancer and Enhances Proliferation through Inhibition of p21
Julia Hoefer et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
FOXA1 Promotes Tumor Progression in Prostate Cancer and Represents a Novel Hallmark of Castration-Resistant Prostate Cancer
Josefine Gerhardt et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Androgen Deprivation Causes Epithelial-Mesenchymal Transition in the Prostate: Implications for Androgen-Deprivation Therapy
Yuting Sun et al.
CANCER RESEARCH (2012)
ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment
Nicola J. Clegg et al.
CANCER RESEARCH (2012)
Distinct Transcriptional Programs Mediated by the Ligand-Dependent Full-Length Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer
Rong Hu et al.
CANCER RESEARCH (2012)
MicroRNA let-7c Suppresses Androgen Receptor Expression and Activity via Regulation of Myc Expression in Prostate Cancer Cells
Nagalakshmi Nadiminty et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Orteronel (TAK-700), a novel non-steroidal 17,20-lyase inhibitor: Effects on steroid synthesis in human and monkey adrenal cells and serum steroid levels in cynomolgus monkeys
Masuo Yamaoka et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2012)
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study
Karim Fizazi et al.
LANCET ONCOLOGY (2012)
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Characterisation of a Tip60 Specific Inhibitor, NU9056, in Prostate Cancer
Kelly Coffey et al.
PLOS ONE (2012)
Discovery of orteronel (TAK-700), a naphthylmethylimidazole derivative, as a highly selective 17,20-lyase inhibitor with potential utility in the treatment of prostate cancer
Tomohiro Kaku et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Histone deacetylase inhibitor valproic acid suppresses the growth and increases the androgen responsiveness of prostate cancer cells
Yu-Wei Chou et al.
CANCER LETTERS (2011)
Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells
Paivi Ostling et al.
CANCER RESEARCH (2011)
Intratumoral De Novo Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors
Changmeng Cai et al.
CANCER RESEARCH (2011)
Phase I Dose-Escalation Study of the Novel Antiandrogen BMS-641988 in Patients with Castration-Resistant Prostate Cancer
Dana Rathkopf et al.
CLINICAL CANCER RESEARCH (2011)
Targeting Continued Androgen Receptor Signaling in Prostate Cancer
Christophe Massard et al.
CLINICAL CANCER RESEARCH (2011)
Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants
Elahe A. Mostaghel et al.
CLINICAL CANCER RESEARCH (2011)
Androgen receptor levels are upregulated by Akt in prostate cancer
Susan Ha et al.
ENDOCRINE-RELATED CANCER (2011)
Alternatively spliced androgen receptor variants
Scott M. Dehm et al.
ENDOCRINE-RELATED CANCER (2011)
miR 488☆ inhibits androgen receptor expression in prostate carcinoma cells
Kavleen Sikand et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Inhibition of the Acetyltransferases p300 and CBP Reveals a Targetable Function for p300 in the Survival and Invasion Pathways of Prostate Cancer Cell Lines
Frederic R. Santer et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Small Molecule Inhibition of the Steroid Receptor Coactivators, SRC-3 and SRC-1
Ying Wang et al.
MOLECULAR ENDOCRINOLOGY (2011)
Androgen-Induced Cell Migration: Role of Androgen Receptor/Filamin A Association
Gabriella Castoria et al.
PLOS ONE (2011)
Expression of Androgen Receptor Splice Variants in Prostate Cancer Bone Metastases is Associated with Castration-Resistance and Short Survival
Emma Hornberg et al.
PLOS ONE (2011)
Androgen Regulation of micro-RNAs in Prostate Cancer
Kati K. Waltering et al.
PROSTATE (2011)
The Anti-Interleukin-6 Antibody Siltuximab Down-Regulates Genes Implicated inTumorigenesis in Prostate Cancer Patients From a Phase I Study
Jayaprakash Karkera et al.
PROSTATE (2011)
Multicenter Phase II Trial of the Heat Shock Protein 90 Inhibitor, Retaspimycin Hydrochloride (IPI-504), in Patients With Castration-resistant Prostate Cancer
William K. Oh et al.
UROLOGY (2011)
Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC)
L. R. Molife et al.
ANNALS OF ONCOLOGY (2010)
Regression of Castrate-Recurrent Prostate Cancer by a Small-Molecule Inhibitor of the Amino-Terminus Domain of the Androgen Receptor
Raymond J. Andersen et al.
CANCER CELL (2010)
Tubulin-Targeting Chemotherapy Impairs Androgen Receptor Activity in Prostate Cancer
Meng-Lei Zhu et al.
CANCER RESEARCH (2010)
Interleukin-6 trans-signalling differentially regulates proliferation, migration, adhesion and maspin expression in human prostate cancer cells
Frederic R. Santer et al.
ENDOCRINE-RELATED CANCER (2010)
Phosphorylation and Activation of Androgen Receptor by Aurora-A
Shao-Kun Shu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Phase II Multicenter Study of Abiraterone Acetate Plus Prednisone Therapy in Patients With Docetaxel-Treated Castration-Resistant Prostate Cancer
Daniel C. Danila et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
FKBP51 Promotes Assembly of the Hsp90 Chaperone Complex and Regulates Androgen Receptor Signaling in Prostate Cancer Cells
Li Ni et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1α/HIF-1β
Paul Cao et al.
MOLECULAR CANCER (2010)
Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study
Howard I. Scher et al.
LANCET (2010)
Dasatinib inhibits site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src kinases
Y. Liu et al.
ONCOGENE (2010)
Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor
Philip A. Watson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
miR-21: An Androgen Receptor-Regulated MicroRNA that Promotes Hormone-Dependent and Hormone-Independent Prostate Cancer Growth
Judit Ribas et al.
CANCER RESEARCH (2009)
Discovery of BMS-641988, a Novel and Potent Inhibitor of Androgen Receptor Signaling for the Treatment of Prostate Cancer
Ricardo M. Attar et al.
CANCER RESEARCH (2009)
A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion-Resistant Growth
Zhiyong Guo et al.
CANCER RESEARCH (2009)
Histone Deacetylases Are Required for Androgen Receptor Function in Hormone-Sensitive and Castrate-Resistant Prostate Cancer
Derek S. Welsbie et al.
CANCER RESEARCH (2009)
The Role of microRNA-221 and microRNA-222 in Androgen-Independent Prostate Cancer Cell Lines
Tong Sun et al.
CANCER RESEARCH (2009)
Interleukin-6 Regulates Androgen Synthesis in Prostate Cancer Cells
Jae Yeon Chun et al.
CLINICAL CANCER RESEARCH (2009)
Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor
Kamilla Malinowska et al.
ENDOCRINE-RELATED CANCER (2009)
Interleukin-6 increases prostate cancer cells resistance to bicalutamide via TIF2
Siting Feng et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
Chris Tran et al.
SCIENCE (2009)
Stimulation of prostate cancer cellular proliferation and invasion by the androgen receptor co-activator ARA70 beta
Yi Peng et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer
Oskar W. Rokhlin et al.
CANCER BIOLOGY & THERAPY (2008)
Targeted overexpression of Vav3 oncogene in prostatic epithelium induces nonbacterial prostatitis and prostate cancer
Yin Liu et al.
CANCER RESEARCH (2008)
The RNA helicase p68 is a novel androgen receptor coactivator involved in splicing and is overexpressed in prostate cancer
Emma L. Clark et al.
CANCER RESEARCH (2008)
The nuclear factor-κB pathway controls the progression of prostate cancer to androgen-independent growth
Ren Jie Jin et al.
CANCER RESEARCH (2008)
Androgen levels increase by intratumoral de novo steroidogenesis during progression of castration-resistant prostate cancer
Jennifer A. Locke et al.
CANCER RESEARCH (2008)
Androgen receptor and invasion in prostate cancer
Takahito Hara et al.
CANCER RESEARCH (2008)
Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation
Angela Seaton et al.
CARCINOGENESIS (2008)
A Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Hormone-Refractory Metastatic Prostate Cancer
Elisabeth I. Heath et al.
CLINICAL CANCER RESEARCH (2008)
Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven
Gerhardt Attard et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Androgen receptor inactivation contributes to antitumor efficacy of 17α-hydroxylase/17,20-lyase inhibitor 3β-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene in prostate cancer
Tadas Vasaitis et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Leupaxin, a novel coactivator of the androgen receptor, is expressed in prostate cancer and plays a role in adhesion and invasion of prostate carcinoma cells
Silke Kaulfuss et al.
MOLECULAR ENDOCRINOLOGY (2008)
Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival
Y. Wang et al.
ONCOGENE (2008)
FOXO3a mediates the androgen-dependent regulation of FLIP and contributes to TRAIL-induced apoptosis of LNCaP cells
A. N. Cornforth et al.
ONCOGENE (2008)
Src kinase potentiates androgen receptor transactivation function and invasion of androgen-independent prostate cancer C4-2 cells
M. Asim et al.
ONCOGENE (2008)
Oligomeric Proanthocyanidin Complexes (OPC) Exert Anti-Proliferative and Pro-Apoptotic Effects on Prostate Cancer Cells
Hannes Neuwirt et al.
PROSTATE (2008)
Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activity
Arnina Zoubeidi et al.
CANCER RESEARCH (2007)
Unexpected paracrine action of prostate cancer cells harboring a new class of androgen receptor mutation-A new paradigm for cooperation among prostate tumor cells
Gaelle Lapouge et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
A 90 kDa fragment of filamin A promotes Casodex-induced growth inhibition in Casodex-resistant androgen receptor positive C4-2 prostate cancer cells
Y. Wang et al.
ONCOGENE (2007)
A splicing variant of the androgen receptor detected in a metastatic prostate cancer exhibits exclusively cytoplasmic actions
Monika Jagla et al.
ENDOCRINOLOGY (2007)
Androgen deprivation increases p300 expression in prostate cancer cells
Hannelore V. Heemers et al.
CANCER RESEARCH (2007)
Neuroendocrine-like prostate cancer cells: Neuroendocrine transdifferentiation of prostate adenocarcinoma cells
Ta-Chun Yuan et al.
ENDOCRINE-RELATED CANCER (2007)
Steroid receptor coactivator-3 and activator protein-1 coordinately regulate the transcription of components of the insulin-like growth factor/AKT signaling pathway
Jun Yan et al.
CANCER RESEARCH (2006)
Identification of genes targeted by the androgen and PKA signaling pathways in prostate cancer cells
G. Wang et al.
ONCOGENE (2006)
Inappropriate activation of the androgen receptor by nonsteroids: Involvement of the Src kinase pathway and its therapeutic implications
Sonal J. Desai et al.
CANCER RESEARCH (2006)
Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer
Irina U. Agoulnik et al.
CANCER RESEARCH (2006)
Androgen induction of prostate cancer cell invasion is mediated by ezrin
Yin-Choy Chuan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Regulation of androgen receptor activity by tyrosine phosphorylation
Zhiyong Guo et al.
CANCER CELL (2006)
Vav3 oncogene is overexpressed and regulates cell growth and androgen receptor activity in human prostate cancer
Zhongyun Dong et al.
MOLECULAR ENDOCRINOLOGY (2006)
Androgen receptor mutation (T877A) promotes prostate cancer cell growth and cell survival
C. Sun et al.
ONCOGENE (2006)
Inhibition of interleukin-6 with CNTO328, an anti-interleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent phenotype in orchiectomized mice
L Wallner et al.
CANCER RESEARCH (2006)
Mechanisms of cell death induced by histone deacetylase inhibitors in androgen receptor-positive prostate cancer cells
OW Rokhlin et al.
MOLECULAR CANCER RESEARCH (2006)
Antiandrogen bicalutamide promotes tumor growth in a novel androgen-dependent prostate cancer xenograft model derived from a bicalutamide-treated patient
T Yoshida et al.
CANCER RESEARCH (2005)
p300 regulates androgen receptor-independent expression of prostate-specific antigen in prostate cancer cells treated chronically with interleukin-6
JD Debes et al.
CANCER RESEARCH (2005)
Interieukin-6 regulation of prostate cancer cell growth
Z Culig et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2005)
Novel C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: Synthesis, in vitro biological activity, pharmacokinetics, and antitumor activity in the LAPC4 human prostate cancer xenograft model
VD Handratta et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
ART-27, an androgen receptor coactivator regulated in prostate development and cancer
SS Taneja et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Epidermal growth factor increases coactivation of the androgen receptor in recurrent prostate cancer
CW Gregory et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The androgen receptor co-activator CBP is up-regulated following androgen withdrawal and is highly expressed in advanced prostate cancer
B Comuzzi et al.
JOURNAL OF PATHOLOGY (2004)
Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer
JI Kreisberg et al.
CANCER RESEARCH (2004)
Steroid hormonal regulation of growth, prostate specific antigen secretion, and transcription mediated by the mutated androgen receptor in CWR22Rv1 human prostate carcinoma cells
BJ Attardi et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2004)
Suppression versus induction of androgen receptor functions by the phosphatidylinositol 3-kinase/Akt pathway in prostate cancer LNCaP cells with different passage numbers
HK Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Interleukin-4 enhances prostate-specific antigen expression by activation of the androgen receptor and Akt pathway
SO Lee et al.
ONCOGENE (2003)
Androgen stimulates matrix metalloproteinase-2 expression in human prostate cancer
XB Liao et al.
ENDOCRINOLOGY (2003)
Expression of Tip60, an androgen receptor coactivator, and its role in prostate cancer development
K Halkidou et al.
ONCOGENE (2003)
Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models
SR Denmeade et al.
PROSTATE (2003)
The transcriptional co-activator cAMP response element-binding protein-binding protein is expressed in prostate cancer and enhances androgen- and anti-androgen-induced androgen receptor function
B Comuzzi et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Pattern of somatic androgen receptor gene mutations in patients with hormone-refractory prostate cancer
ER Hyytinen et al.
LABORATORY INVESTIGATION (2002)
Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells
T Ueda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways
T Ueda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer
VJ Gnanapragasam et al.
BRITISH JOURNAL OF CANCER (2001)
Androgen receptor alterations in prostate cancer relapsed during a combined androgen blockade by orchiectomy and bicalutamide
K Haapala et al.
LABORATORY INVESTIGATION (2001)
Interleukin-6 is an autocrine growth factor in human prostate cancer
D Giri et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Silymarin inhibits function of the androgen receptor by reducing nuclear localization of the receptor in the human prostate cancer cell line LNCaP
W Zhu et al.
CARCINOGENESIS (2001)
Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells
M Gross et al.
ONCOGENE (2001)
Inhibition of LNCaP prostate cancer cells by means of androgen receptor antisense oligonucleotides
IE Eder et al.
CANCER GENE THERAPY (2000)
Share Paper
